News Focus
News Focus
icon url

DewDiligence

04/11/21 3:17 PM

#237718 RE: DewDiligence #232159

LLY’s Retevmo shows activity in various solid tumors:

https://www.biopharmadive.com/news/lilly-retevmo-aacr-ret-fusion-cancer/598169/
icon url

DewDiligence

09/22/22 12:37 PM

#243911 RE: DewDiligence #232159

FDA expands LLY’s Retevmo label to include all RET-based cancers and converts 2020 accelerated approval into full approval:

https://finance.yahoo.com/news/fda-approves-lillys-retevmo-selpercatinib-231200180.html